|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.00 EUR | -1.28% |
|
-3.74% | -2.09% |
| 01-07 | BioMérieux Slips Despite Intensifying Flu Season Across the Atlantic |  |
| 12-04 | Biomerieux Launches Leading Endocrinology Testing Offer Dedicated to Enhancing Equine Health | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 27.81x | 2.84x | 3.45x | 3.05x | 12.43x | 17.95x | 0.83% | 15.08B | |
| -34.89x | -33.38x | 2.6x | 14.88x | -67.17x | -35.65x | -.--% | 13.86B | |
| -20x | - | 0.39x | 9.35x | 108.54x | -180.75x | - | 7.22B | |
| 28.19x | 5.01x | -3.56x | 9.82x | 22.61x | 24.79x | 1.98% | 6.81B | |
| 21.4x | 2.14x | 8.7x | 3.7x | 11.2x | 15.61x | 1.62% | 4.63B | |
| 21.43x | - | -0.77x | 3.09x | 8.39x | 8.75x | - | 4.47B | |
| 18.29x | 2.34x | -14.46x | - | - | - | 3.32% | 3.06B | |
| -39.48x | 3.13x | 0.59x | 3.22x | -43.89x | -27.07x | -.--% | 2.51B | |
| 39.52x | 1.26x | -3.03x | 5.19x | 17.37x | -24.36x | 0.78% | 1.92B | |
| 35.45x | 1.64x | 1.47x | - | - | - | 2.51% | 1.7B | |
| -1947x | 2.72x | 17.52x | - | - | - | - | 1.69B | |
| 25.74x | 1.71x | -0.78x | - | - | - | - | 1.39B | |
| 24.78x | 4.16x | 0.66x | 6.05x | 17.27x | 19.07x | 1.35% | 1.21B | |
| -39.77x | 2.46x | 0.15x | - | - | - | - | 1.16B | |
| 15.05x | 1.82x | 5.42x | - | - | - | 2.87% | 1.17B | |
| 29.78x | 1.12x | 0.32x | - | - | - | 1.34% | 1.03B | |
| Average | -112.11x | -0.07x | 1.17x | 6.48x | 9.64x | -20.18x | 1.51% | 4.31B | |
| Weighted average by Cap. | -42.70x | -5.90x | 1.36x | 7.67x | 3.95x | -23.22x | 1.05% |
- Stock Market
- Equities
- BIM Stock
- Sector bioMérieux
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition